Jonathan L. Slaughter

Jonathan L. Slaughter

Auto-generated profile, based on publicly available information

Jonathan L. Slaughter

Nationwide Children’s Hospital, Columbus, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2011 in Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
JSJ L Slaughter
J L Slaughter
TPT Pakrashi
T Pakrashi
DJD E Jones
D E Jones
ASA P South
A P South
TST A Shah
T A Shah

3 September 2022 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
CBCarl H. Backes
Carl H. Backes
KHKevin D. Hill
Kevin D. Hill
ESElaine L. Shelton
Elaine L. Shelton
JSJonathan L. Slaughter
Jonathan L. Slaughter
TLTamorah Lewis
Tamorah Lewis
VGVidu Garg
Vidu Garg
The burden of patent ductus arteriosus (PDA) continues to be significant. In view of marked differences in preterm infants versus more mature, term counterparts (viewed on a continuum with adolescent and adult patients), mechanisms regulating ductal patency, genetic contributions, clinical consequences, and diagnostic and treatment thresholds are discussed separately, when appropriate. Among both preterm infants and older children and adults, a range of hemodynamic profiles highlighting the markedly variable consequences of the PDA are provided. In most contemporary settings, transcatheter closure is preferable over surgical ligation, but data on longer‐term outcomes, particularly among preterm infants, are lacking. The present review provides recommendations to identify gaps in PDA diagnosis, management, and treatment on which subsequent research can be developed. Ultimately, the combination of refined diagnostic thresholds and expanded treatment options provides the best opportunities to address the burden of PDA. Although fundamental gaps remain unanswered, the present review provides pediatric and adult cardiac care providers with a contemporary framework in PDA care to support the practice of evidence‐based medicine.

1 February 2017 in The Journal of Pediatrics
Verified
Journal Article
Closed access
SJSudarshan R. Jadcherla
Sudarshan R. Jadcherla
TKTanvi Khot
Tanvi Khot
RMRebecca Moore
Rebecca Moore
MMManish Malkar
Manish Malkar
IGIsh K. Gulati
Ish K. Gulati
JSJonathan L. Slaughter
Jonathan L. Slaughter

14 January 2013 in Journal of Child Neurology
Verified
Journal Article
Closed access
PDF file
LSLaurel A. Slaughter
Laurel A. Slaughter
APAnup D. Patel
Anup D. Patel
JSJonathan L. Slaughter
Jonathan L. Slaughter
Pharmacologic treatment options for neonatal seizures have expanded over the past 2 decades, and there is no consensus on optimal treatment strategy. We systematically reviewed the published literature to determine which medication(s) are most effective for treating neonatal seizures, by retrieving trials and observational investigations via PubMed (through August 2011) that focused on pharmacological seizure treatment of neonates (≤ 28 days old) and utilized continuous or amplitude-integrated EEG to confirm seizure diagnosis and cessation. Our search identified 557 initial articles and 14 additional studies after reference reviews, with 16 meeting inclusion criteria. Of these, 2 were randomized trials and only 3 additional investigations included comparison groups. We found limited evidence regarding the best pharmacologic treatment for neonatal seizures, but were able to devise a treatment algorithm from available data. These findings have the potential to serve as a clinical reference and to inform the design of comparative effectiveness investigations for neonatal antiepileptics.

13 July 2013 in Archives of Disease in Childhood - Fetal and Neonatal Edition
Verified
Journal Article
Open access
NMNagendra Monangi
Nagendra Monangi
JSJonathan L Slaughter
Jonathan L Slaughter
ADAdekunle Dawodu
Adekunle Dawodu
CSCarrie Smith
Carrie Smith
HAHenry T Akinbi
Henry T Akinbi
Objectives: To evaluate vitamin D (vitD) status in early preterm infants (EPTIs) at birth and during birth hospitalisation on current vitD intake. Design/methods: Serum 25-hydroxyvitamin-D [25(OH)D] concentrations, vitD intake and risk factors for low vitD status were assessed in 120 infants born at ≤32 weeks gestation. Results: Mean (SD) serum 25(OH)D at birth was 46.2 (14.0) nmol/L with lower concentrations in infants born <28 weeks than at 28–32 weeks gestation, p=0.02. Serum 25(OH)D was <50 nmol/L in 63% of mothers, 64% of infants at birth and 35% of infants at discharge. Mean daily vitD intake was 289±96 IU at 4 weeks of age and 60% achieved 400 IU/day intake at discharge. Conclusions: Serum 25(OH)D <50 nmol/L was widespread in parturient women and in EPTIs at birth and at discharge. Optimising maternal vitD status during pregnancy and improving postnatal vitD intake may enhance infant vitD status during hospitalisation.

1 April 2013 in Pediatrics
Verified
Journal Article
Closed access
JSJonathan L. Slaughter
Jonathan L. Slaughter
MSMichael R. Stenger
Michael R. Stenger
PRPatricia B. Reagan
Patricia B. Reagan
OBJECTIVES: To determine (1) between-hospital variation in diuretic use for infants with bronchopulmonary dysplasia (BPD), including hospital-specific treatment frequency, treatment duration, and percentage of infants receiving short (≤5 consecutive days) versus longer (>5 days) courses, and to determine (2) demographic and clinical variables associated with diuretic administration.METHODS: A retrospective cohort study was conducted with the use of the Pediatric Health Information System to determine between-hospital variation in diuretic utilization patterns (primary outcome) and variables associated with diuretic use among 5 consecutive days. Furosemide was the most widely prescribed diuretic (1218 infants; 85%), although chlorothiazide had the longest median duration of use (21 days; 25th–75th percentile: 8–46 days). The range of infants receiving a diuretic course of >5 days duration varied by hospital from 4% to 86%, with wide between-hospital variation even after adjustment for confounding variables.CONCLUSIONS: The frequency of diuretic administration to infants with BPD at US children’s hospitals, as well as the specific diuretic regimen used, varies markedly by institution. Safety and effectiveness research of long-term diuretic therapy for BPD patients is needed to develop evidence-based recommendations.